BioLife Solutions, Inc. Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted
BioLife Solutions, Inc. (BLFS) reported Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted of $0 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted · last filed 2025-08-07
- BioLife Solutions, Inc. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2025-06-30 was $0.00.
- BioLife Solutions, Inc. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2025-03-31 was $0.00.
- BioLife Solutions, Inc. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2024-09-30 was $0.00.
- BioLife Solutions, Inc. net income (loss) from discontinued operations available to common shareholders, diluted for the quarter ending 2024-06-30 was -$15.16M.
| Period end | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 3 month as first filed | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 6 month as first filed | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted 9 month |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | -$15.16M derived: sum of 2 quarters · filed 2025-08-07 | -$19.58M 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | -$15.16M 10-Q · filed 2025-08-07 | -$13.57M 10-Q · filed 2024-08-09 | -$22.18M 10-Q · filed 2025-08-07 | -$19.58M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | -$7.02M 10-Q · filed 2025-05-08 | ||||
| 2023-09-30 | -$13.33M 10-Q · filed 2024-11-12 | -$18.01M derived: sum of 2 quarters · filed 2024-11-12 | -$23.00M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$4.68M 10-Q · filed 2024-08-09 | -$9.67M 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |